Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jan 1;46(1):43-45.
doi: 10.1097/DAD.0000000000002580. Epub 2023 Oct 26.

Spontaneous Regression of Primary Cutaneous Diffuse Large B-Cell Lymphoma on Sequential FDG PET

Affiliations
Case Reports

Spontaneous Regression of Primary Cutaneous Diffuse Large B-Cell Lymphoma on Sequential FDG PET

Jason Ghossein et al. Am J Dermatopathol. .

Abstract

Primary cutaneous diffuse large B-cell lymphoma, leg type is a rare, aggressive lymphoma characterized by skin involvement predominantly in the lower extremities. We present a case of an elderly woman with pathology diagnosis of primary cutaneous diffuse large B-cell lymphoma, leg type with spontaneous regression without systematic therapy documented by sequential FDG PET scans and clinical follow-up.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Grange F, Beylot-Barry M, Courville P, et al. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol. 2007;143:1144–1150.
    1. Walter HS, Trethewey CS, Ahearne MJ, et al. Successful treatment of primary cutaneous diffuse large B-cell lymphoma leg type with single-agent venetoclax. JCO Precision Oncol. 2019;3:1–5.
    1. Hristov AC. Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations. Arch Pathol Lab Med. 2012;136:876–881.
    1. Willemze R. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–3785.
    1. Jessy T. Immunity over inability: the spontaneous regression of cancer. J Nat Sci Biol Med. 2011;2:43–49.

Publication types

Substances